Hydrochloric Acid

Hydrochloric Acid

SCHEMBL134929

Cl.Cl.Cl.Cl.Nc1ccc(-c2ccc(N)c(N)c2N)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCZ known ✓ Q05513 1/20 0.33
MAOA known ✓ P21397 1/20 0.32
MAOB known ✓ P27338 1/20 0.32
CA2 known ✓ P00918 1/20 0.32
KIT known ✓ P10721 2/20 0.32
KDR known ✓ P35968 2/20 0.32
FLT3 known ✓ P36888 2/20 0.32
GAA known ✓ P10253 1/20 0.31
CYP3A4 P08684 4/20 0.46
ALDH1A1 P00352 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
TP53 P04637 3/20 0.46
HSD17B10 Q99714 4/20 0.39
TAAR1 Q96RJ0 2/20 0.39
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
APP P05067 1/20 0.36
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL992776 1.00 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL999548 1.00 CYP3A4 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL28335260 0.98 ALDH1A1 (0.43) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL28663126 0.98 ALDH1A1 (0.43) CYP3A4ALDH1A1TDP1TP53HSD17B10
Hydrochloric Acid SCHEMBL3504243 0.98 ALDH1A1 (0.43) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL30272720 0.98 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL5983370 0.98 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL21373 0.98 TDP1 (0.48) CYP3A4ALDH1A1TDP1TP53HSD17B10
SCHEMBL3507048 0.95 TDP1 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10
Water SCHEMBL7066183 0.95 TDP1 (0.46) CYP3A4ALDH1A1TDP1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2300 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118533806-A Research method for water flooding resistant molecular characteristics of super arundo donax 郑州大学 2024-08-23 CN claimed
WO-2021111461-A1 NANOZYME LINKED OLIGO PROBE SORBENT ASSAY (NLOPSA) FOR THE DETECTION OF NUCLEIC ACID BIOMARKERS INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IIT Madras) (IN) 2021-06-10 WO claimed
CN-108982834-B Method for detecting biological molecules by using nano enzyme immune sandwich novel technology 公安部物证鉴定中心 2021-04-23 CN claimed
CN-111103430-A Diagnostic kit for evaluating efficacy and safety of liposome drug 复旦大学 2020-05-05 CN claimed
US-10557851-B2 Signaling conjugates and methods of use VENTANA MEDICAL SYSTEMS, INC. (US) 2020-02-11 US claimed
US-20170199179-A1 PD-IR NANOPARTICLES USED AS PEROXIDASE MIMICS MICHIGAN TECHNOLOGICAL UNIVERSITY 2017-07-13 US claimed
CN-106365243-A Abandoned flow type rainwater depth cyclic purification device and purification processes thereof 徐州工程学院 2017-02-01 CN claimed
EP-3096140-A1 NANOMETER MIMIC ENZYME IMMUNOCHROMATOGRAPHY DETECTION METHOD The Institute of Biophysics Chinese Academy of Sciences (CN) 2016-11-23 EP claimed
US-20160334397-A1 NANOZYME IMMUNOCHROMATOGRAPHIC DETECTION METHOD GILL BIOTECHNOLOGY (TIANJIN) CO., LTD., (CN) 2016-11-17 US claimed
US-20160103044-A1 DEVICES AND METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION BY ENRICHING RARE CELLS FIRST-CITIZENS BANK & TRUST COMPANY 2016-04-14 US claimed
EP-0975973-A1 METHOD FOR DETERMINING THE PRESENCE OF MUTATED BRCA PROTEIN Baystate Medical Center (US) 2000-02-02 EP claimed
US-5965377-A SCREENING FOR SUSCEPTIBILITY TO BREAST AND OVARIAN CANCER; USING AN ANTIBODY BASED METHOD, TARGETING SPECIFIC CARBOXY-TERMINUS MUTATIONS IN PROTEIN EXPRESSED IN EPITHELIAL CELLS, MEASURING ANTIBODY REACTIVITY WITH PROTEIN BAYSTATE MEDICAL CENTER (US) 1999-10-12 US claimed
US-5902727-A SIMPLE AND EFFICIENT ANALYSIS BY BINDING ENZYME LINKED PROBE TO TARGET, ADDING SUBSTRATE(S), DETECTING INSOLUBLE AND SOLUBLE PRODUCTS WASHINGTON UNIVERSITY (US) 1999-05-11 US claimed
WO-1998043092-A1 METHOD FOR DETERMINING THE PRESENCE OF MUTATED BRCA PROTEIN BAYSTATE MEDICAL CENTER (US) 1998-10-01 WO claimed
WO-1998010290-A1 METHOD FOR LOCALIZATION AND QUANTITATION OF A SUBSTANCE IN A BIOLOGICAL SAMPLE WASHINGTON UNIVERSITY (US) 1998-03-12 WO claimed
EP-0618300-A1 TMB formulation for soluble and precipitable HRP-ELISA BioVest, Inc. (US) 1994-10-05 EP claimed
EP-0456782-A1 TMB FORMULATION FOR SOLUBLE AND PRECIPITABLE HRP-ELISA. TSI CORP (US) 1991-11-21 EP claimed
WO-1991006672-A1 TMB FORMULATION FOR SOLUBLE AND PRECIPITABLE HRP-ELISA TSI-MASON RESEARCH INSTITUTE (US) 1991-05-16 WO claimed
US-5006461-A Chromogens forms stable precipitate with polymer TRANSGENIC SCIENCES, INC. (US) 1991-04-09 US claimed
US-4390274-A Use of a method, particularly an automatic method, for measuring light as well as improvements and apparatuses for carrying out the same MINNESOTA MINING AND MANUFACTURING COMPANY, A CORP OF DE. 1983-06-28 US claimed